Both ALKBH5 and FTO can regulate the cancer epigenome through demethylation of mRNA m6A, leading to changes in the ability of cells to survive, proliferate, invade, and metastasize as alterations in drug sensitivity, cancer stem cell status, and cancer immunity. This evidence concerns the gene ALKBH5 and cancer.